Dustin Davis is an associate in the Washington, D.C. office of Latham & Watkins, and a member of the Private Equity and Mergers & Acquisitions Practices.

Dustin represents public and private companies, private equity firms and their portfolio companies, and strategic investors in connection with US and cross-border corporate and transactional matters, including public and private mergers and acquisitions, private equity investments, controlling and minority investments, preferred equity financings, joint ventures and consortium arrangements, portfolio company add-on transactions, carve-out acquisitions and divestitures, corporate reorganizations and recapitalizations, corporate governance, and general corporate matters.

Dustin advises clients in a variety of industries, including aerospace and defense, healthcare, industrials and manufacturing, entertainment and media, automotive, and technology, among others.

Dustin’s experience includes advising:

  • The Carlyle Group in its strategic investment in Entertainment 360, one of the world’s premier talent management companies
  • CorroHealth, a leading provider of revenue cycle management (RCM) solutions to health systems and health plans, and The Carlyle Group in connection with Patient Square Capital’s strategic investment in CorroHealth and sharing joint control of CorroHealth with The Carlyle Group
  • The Carlyle Group in its US$1.5 billion acquisition of Worldpac from Advance Auto Parts, Inc. (NYSE: AAP)
  • StandardAero and The Carlyle Group in connection with StandardAero’s upsized US$1.44 billion IPO
  • A portfolio company of The Carlyle Group in its acquisition of a healthcare automation and patient engagement software company
  • A portfolio company of The Carlyle Group in its US$365 million carve-out acquisition of the medical software technology business of a publicly traded company
  • Permira in its strategic investment in a public safety software technology company
  • A portfolio company of The Carlyle Group in its US$100 million carve-out acquisition of a medical software technology company
  • A medical device technology company in its cash and stock acquisition of certain assets of a publicly traded medical company
  • Revolution Medicines (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, in its US$1 billion+ all-stock acquisition of EQRx, Inc. (Nasdaq: EQRX)
  • A middle market private equity firm in the US$250 million sale of its portfolio company, a water infrastructure technology company, to another leading private equity firm
  • An infrastructure private equity firm in a series of cross-border telecommunications infrastructure transactions
  • A financial software company in its series seed financing
  • A digital tipping payments platform company in its series seed financing
  • SMART Global Holdings (Nasdaq: SGH) in its acquisition of Stratus Technologies
  • BigCommerce (Nasdaq: BIGC) in its acquisition of Bundle B2B
  • An AI customer success-focused company in its series seed financing
  • SourceDay in its US$31.5 million Series C financing
  • Affinaquest (formerly SSB Consulting) in its business unit divestiture to KORE software
  • Tritium Partners in its growth equity investment in a leading cross-border consolidated freight service and solutions provider*
  • Silicon Labs (Nasdaq: SLAB) in its modified Dutch auction tender offer to purchase up to US$1 billion of its common stock*
  • Rice Acquisition Corp., a special purpose acquisition vehicle, in its US$1.15 billion business combination with Aria Energy and Archaea Energy to form Archaea Energy (NYSE: LFG), a publicly traded renewable natural gas platform*
  • CleanCapital in its US$300 million equity raise for a new solar and storage platform and acquisition of two C&I solar portfolios*
  • KKR in its US$1.4 billion joint investment with NextEra Energy Resources (NYSE: NEE) and NextEra Energy Partners (NYSE: NEP) to acquire a portfolio of wind and solar energy assets*
  • Charter Communications (Nasdaq: CHTR) in its strategic investment in Comscore (Nasdaq: SCOR)*
  • Hilcorp Alaska in its US$5.6 billion acquisition of BP’s (NYSE: BP) upstream and midstream Alaska businesses*
  • Schlumberger Limited (NYSE: SLB) in the sale of its North American onshore hydraulic fracturing business to Liberty Energy (NYSE: LBRT)*
  • Warburg Pincus in its US$1 billion controlling investment in an exploration and production company*

*Matter handled prior to joining Latham

Bar Qualification

  • District of Columbia
  • Texas

Education

  • JD, Vanderbilt University Law School, 2019
  • BA in Economics & American Studies, University of Alabama, 2016